N/A
N=217
Central Venous Access Study
Central Line Catheters
Bottom Line
View on ClinicalTrials.gov: NCT03480542 ↗Enrolled (actual)
217
Serious AEs
—
Results posted
Jun 2024
Primary outcome: Primary: Adherence to Clinical Guidelines for Catheter Interventions and Management — 12; 0; 0; 11 # of catheter-related incidents
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Adult, Older Adult · 22+ yrs
- Sex
- All
- Sponsor
- Hackensack Meridian Health
- Primary completion
- Apr 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Adherence to Clinical Guidelines for Catheter Interventions and Management |
12; 0; 0; 11; 15; 0 | — |
| SECONDARY Number of Documented Catheter Complications |
0; 0; 0; 0; 0; 0 | — |
Summary
The aim of this study is to document clinicians variation in practice in comparison to standard guidelines by the Medical Center's approved Evidence-based Practice (EBP) guidelines, policies, and procedures for Central Venous Catheter(CVC), Peripherally Inserted Central Catheter (PICC), and Hemodialysis (HD catheters by way of a structured retrospective review of the Electronic Medical Record (EMR) system.
Eligibility Criteria
Inclusion Criteria
- Adult patients in Medical Intensive Care Unit (MICU), Coronary Care Unit (CCU), Cardiac Surgical Intensive Care Unit (CSICU), Surgical Intensive Care Unit (SICU) with either CVCs, PICCs, or HD catheters.
Exclusion Criteria
- Pediatric (including neonates), obstetric and gynecology, medical-surgical, and oncology patients.
Data sourced from ClinicalTrials.gov (NCT03480542). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.